Publications by authors named "Maria Florencia Gomez Castro"

Diarrhea is the predominant symptom of acute gastroenteritis resulting from enteric infections and a leading cause of death in infants and young children. However, the role of the host response in diarrhea pathogenesis is unclear. Using rotavirus and neonatal mice as a model, we found that oral inoculation of UV-inactivated replication-defective rotavirus consistently induced watery diarrhea by robust activation of cytosolic double-stranded RNA sensing pathways and type III interferon (IFN-λ) secretion.

View Article and Find Full Text PDF

Pathogenic coronaviruses are a major threat to global public health. Here, using a recombinant reporter virus-based compound screening approach, we identified small-molecule inhibitors that potently block the replication of severe acute respiratory syndrome virus 2 (SARS-CoV-2). Among them, JIB-04 inhibited SARS-CoV-2 replication in Vero E6 cells with a 50% effective concentration of 695 nM, with a specificity index of greater than 1,000.

View Article and Find Full Text PDF
Article Synopsis
  • - Researchers found that even though SARS-CoV-2 (the virus causing COVID-19) engages with immune cells, these cells typically don’t have the primary receptor (ACE2) for the virus.
  • - They identified several other receptors on myeloid cells, like DC-SIGN and L-SIGN, that interact with parts of the virus's spike protein and trigger strong inflammatory responses, which are linked to more severe COVID-19 cases.
  • - The study also led to the development of a new nanobody that can block both the virus’s infection through ACE2 and the harmful inflammatory responses caused by myeloid cell receptors, highlighting potential new treatment strategies for COVID-19.
View Article and Find Full Text PDF

Cholesterol 25-hydroxylase () is an interferon (IFN)-stimulated gene that shows broad antiviral activities against a wide range of enveloped viruses. Here, using an IFN-stimulated gene screen against vesicular stomatitis virus (VSV)-SARS-CoV and VSV-SARS-CoV-2 chimeric viruses, we identified CH25H and its enzymatic product 25-hydroxycholesterol (25HC) as potent inhibitors of SARS-CoV-2 replication. Internalized 25HC accumulates in the late endosomes and potentially restricts SARS-CoV-2 spike protein catalyzed membrane fusion via blockade of cholesterol export.

View Article and Find Full Text PDF

Pathogenic coronaviruses represent a major threat to global public health. Here, using a recombinant reporter virus-based compound screening approach, we identified several small-molecule inhibitors that potently block the replication of the newly emerged severe acute respiratory syndrome virus 2 (SARS-CoV-2). Among them, JIB-04 inhibited SARS-CoV-2 replication in Vero E6 cells with an EC of 695 nM, with a specificity index of greater than 1,000.

View Article and Find Full Text PDF
Article Synopsis
  • COVID-19 patients often experience gastrointestinal symptoms and shed SARS-CoV-2 RNA in their feces, but the role of the intestine in the virus's transmission remains uncertain.
  • Research shows that SARS-CoV-2 can infect mature enterocytes in the human small intestine, aided by specific proteases that help the virus enter cells.
  • Despite this potential replication site in the intestine, experiments indicate that the virus is inactivated in the gut and infectious virus isn't found in the stool of patients, suggesting limited fecal-oral transmission.
View Article and Find Full Text PDF

Celiac disease (CeD) is a highly prevalent chronic immune-mediated enteropathy developed in genetically predisposed individuals after ingestion of a group of wheat proteins (called gliadins and glutenins). The 13mer α-gliadin peptide, p31-43, induces proinflammatory responses, observed by in vitro assays and animal models, that may contribute to innate immune mechanisms of CeD pathogenesis. Since a cellular receptor for p31-43 has not been identified, this raises the question of whether this peptide could mediate different biological effects.

View Article and Find Full Text PDF

Celiac disease (CD) is a chronic enteropathy elicited by a Th1 response to gluten peptides in the small intestine of genetically susceptible individuals. However, it remains unclear what drives the induction of inflammatory responses of this kind against harmless antigens in food. In a recent work, we have shown that the p31-43 peptide (p31-43) from α-gliadin can induce an innate immune response in the intestine and that this may initiate pathological adaptive immunity.

View Article and Find Full Text PDF

Celiac disease (CD) is an immune-mediated enteropathy triggered by gluten in genetically susceptible individuals. Innate immunity contributes to the pathogenesis of CD, but the mechanisms remain poorly understood. Although previous in vitro work suggests that gliadin peptide p31-43 acts as an innate immune trigger, the underlying pathways are unclear and have not been explored in vivo.

View Article and Find Full Text PDF